CLSA expands Board Of Directors with industry and academic leaders from across the Golden State
Will Zasadny (CLSA) | Aug 28, 2017 | California
California Life Sciences Association (CLSA), the state’s premier public policy and business solutions organization representing California’s life sciences sector, today announced a major expansion to its advocacy team, hiring three new government relations directors based in its Sacramento and Washington, D.C. offices, bringing its in-house advocacy staff count to nine
SACRAMENTO – California NAACP joins the California Chronic Care Coalition, California Senior Advocates League, Friedreich’s Ataxia Research Alliance (FARA), Council for Citizens Against Government Waste, TechNet, California Hepatitis C Task Force and others to voice concerns regarding SB 1010, a bill by State Sen. Ed Hernandez, which prioritizes paperwork, red
SAN FRANCISCO & SAN DIEGO, CA – Today, California Life Sciences Association (CLSA) announced its board of directors has appointed three new members: Ben Thorner, Vice President, BD&L and Head of North American Innovation Hubs, Merck; Keith Murphy, Chairman and Chief Executive Officer, Organovo; and Dave Anderson, Vice President, Merger
SACRAMENTO – Patients and the life sciences community have partnered to protect access to new medicines and oppose SB 1010. The bill, by Sen. Ed Hernandez, prioritizes paperwork and bureaucracy over research, and instead of improving patient access and affordability, places patients in California at the end of the line.
H.R. 5009 bridges Medicare patient access gaps and modernizes policies to allow coverage of technologies approved through FDA’s expedited review process Washington, DC (April 21, 2016) – California Life Sciences Association (CLSA), the statewide public policy organization representing over 750 of California’s leading life science innovators, lauded the introduction of
Sacramento, CA--California Life Sciences Association (CLSA), the statewide public policy organization representing over 750 of California’s leading life sciences innovators, issued the following statement opposing SB 1010. This statement can be attributed to Sara Radcliffe, President & CEO, California Life Sciences Association (CLSA): “As innovators in the life sciences sector